Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology
- 29 May 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 45 (6), 1413-1421
- https://doi.org/10.1002/hep.21608
Abstract
Hepatitis C virus (HCV) replication is highly dependent on host cell factors. Identification of these host factors not only facilitates understanding of the biology of HCV infection but also enables the discovery of novel targets for anti‐HCV therapy. To identify host genes important for HCV RNA replication, we screened a library of small interfering RNA (siRNA) that targets approximately 4,000 human genes in Huh7‐derived EN5‐3 cells harboring an HCV subgenomic replicon with the nonstructural region NS3‐NS5B from the 1b‐N strain. Nine cellular genes that potentially regulate HCV replication were identified in this screen. Silencing of these genes resulted in inhibition of HCV replication by more than 60% and exhibited minimal toxicity. Knockdown of host gene expression by these siRNAs was confirmed at the RNA level and, in some instances, at the protein level. The level of siRNA silencing of these host genes correlated well with inhibition of HCV. These genes included those that encoded a G‐protein coupled receptor (TBXA2R), a membrane protein (LTβ), an adapter protein (TRAF2), 2 transcription factors (RelA and NFκB2), 2 protein kinases (MKK7 and SNARK), and 2 closely related transporter proteins (SLC12A4 and SLC12A5). Of interest, some of these genes are members of the tumor necrosis factor/lymphotoxin signaling pathway. Conclusion: Findings of this study may provide important information for understanding HCV replication. In addition, these cellular genes may constitute a novel set of targets for HCV antiviral therapy. (HEPATOLOGY 2007.)Keywords
This publication has 51 references indexed in Scilit:
- Hepatitis C Virus Core Protein Inhibits Tumor Necrosis Factor Alpha-Mediated Apoptosis by a Protective Effect Involving Cellular FLICE Inhibitory ProteinJournal of Virology, 2006
- VX-950, a Novel Hepatitis C Virus (HCV) NS3-4A Protease Inhibitor, Exhibits Potent Antiviral Activities in HCV Replicon CellsAntimicrobial Agents and Chemotherapy, 2006
- SCH 503034, a Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease, Suppresses Polyprotein Maturation and Enhances the Antiviral Activity of Alpha Interferon in Replicon CellsAntimicrobial Agents and Chemotherapy, 2006
- Binding Site Characterization and Resistance to a Class of Non-nucleoside Inhibitors of the Hepatitis C Virus NS5B PolymeraseJournal of Biological Chemistry, 2005
- Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In VitroAntimicrobial Agents and Chemotherapy, 2005
- The Hepatitis C Virus NS5A Protein Activates a Phosphoinositide 3-Kinase-dependent Survival Signaling CascadePublished by Elsevier BV ,2004
- An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virusNature, 2003
- Appendix: The National Institutes of Health Consensus Development Conference: Management of Hepatitis C 2002Clinics in Liver Disease, 2003
- Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular TransformationThe Journal of Experimental Medicine, 2002
- Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformationThe EMBO Journal, 2000